Charles Schwab’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Sell |
251,365
-137,984
| -35% | -$160K | ﹤0.01% | 3318 |
|
|
2025
Q1 | $526K | Sell |
389,349
-70,035
| -15% | -$94.5K | ﹤0.01% | 3070 |
|
|
2024
Q4 | $6.05M | Buy |
459,384
+2,721
| +0.6% | +$35.8K | ﹤0.01% | 2251 |
|
|
2024
Q3 | $5.12M | Buy |
456,663
+19,281
| +4% | +$216K | ﹤0.01% | 2366 |
|
|
2024
Q2 | $4.7M | Buy |
437,382
+7,096
| +2% | +$76.3K | ﹤0.01% | 2384 |
|
|
2024
Q1 | $6.41M | Buy |
430,286
+6,090
| +1% | +$90.7K | ﹤0.01% | 2195 |
|
|
2023
Q4 | $7.68M | Buy |
424,196
+5,990
| +1% | +$108K | ﹤0.01% | 2126 |
|
|
2023
Q3 | $7.25M | Buy |
418,206
+61,376
| +17% | +$1.06M | ﹤0.01% | 2083 |
|
|
2023
Q2 | $6.47M | Buy |
356,830
+140,314
| +65% | +$2.54M | ﹤0.01% | 2121 |
|
|
2023
Q1 | $5.76M | Buy |
216,516
+43,860
| +25% | +$1.17M | ﹤0.01% | 2136 |
|
|
2022
Q4 | $3.34M | Buy |
172,656
+3,778
| +2% | +$73K | ﹤0.01% | 2398 |
|
|
2022
Q3 | $3.53M | Buy |
168,878
+72,336
| +75% | +$1.51M | ﹤0.01% | 2398 |
|
|
2022
Q2 | $774K | Sell |
96,542
-70,235
| -42% | -$563K | ﹤0.01% | 2889 |
|
|
2022
Q1 | $1.17M | Buy |
166,777
+4,789
| +3% | +$33.6K | ﹤0.01% | 2791 |
|
|
2021
Q4 | $2.19M | Buy |
161,988
+3,827
| +2% | +$51.7K | ﹤0.01% | 2680 |
|
|
2021
Q3 | $2.67M | Buy |
158,161
+63,282
| +67% | +$1.07M | ﹤0.01% | 2630 |
|
|
2021
Q2 | $2.76M | Buy |
94,879
+1,358
| +1% | +$39.5K | ﹤0.01% | 2612 |
|
|
2021
Q1 | $3.68M | Buy |
93,521
+29,576
| +46% | +$1.16M | ﹤0.01% | 2442 |
|
|
2020
Q4 | $1.45M | Buy |
63,945
+933
| +1% | +$21.2K | ﹤0.01% | 2681 |
|
|
2020
Q3 | $1.43M | Buy |
+63,012
| New | +$1.43M | ﹤0.01% | 2594 |
|